Skip to content

The Relationship Between Inflammatory ARTritis and CArdiac DIseAse

Prevalence and Risk Factors Associated With Cardiac Comorbidity in Inflammatory Arthritis - A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05647577
Acronym
ARTCADIA
Enrollment
1285
Registered
2022-12-12
Start date
2021-01-01
Completion date
2033-03-01
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial Spondyloarthritis, Cardiac Disease, Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic, Inflammatory Arthritis, Ischemic Heart Disease, Left Ventricular Systolic Dysfunction, Myocardial Dysfunction, Myocardial Infarction, Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Stroke, Valvular Heart Disease

Brief summary

The goal of this prospective cohort study is to investigate cardiac comorbidity in a random sample of approximately 1200 patients from a population of outpatients with rheumatoid arthritis and axial spondyloarthritis referred to collectively as inflammatory arthritis (IA). The main questions it aims to answer are: * Using conventional echocardiography, the investigators aim to determine the prevalence of overt and asymptomatic cardiac dysfunction in a large random sample of outpatients with IA. Cardiac dysfunction will be evaluated by echocardiography and cardiac biomarkers (NT-pro-BNP, hs-TNT and hs-CRP). * In patients without known heart disease: Using 2, 5 and 10 year follow-up, the investigators aim to examine if advanced echocardiography can be used to detect early signs of heart disease by investigating the clinical significance of adding deformation measures - alone and in combination with selected biomarkers - to conventional risk factors in the cardiac risk assessment of patients with IA Participants will undergo an echocardiographic examination in combination with a general health assessment including obtainment of cardiac biomarkers and a electrocardiogram. Using advanced echocardiography - Tissue Doppler Imaging, 2- dimensional speckle tracking echocardiography, 3D-echocardiography and 3-dimensional speckle tracking echocardiography - the investigators also aim to compare myocardial deformation parameters of patients with IA to a gender and age matched control group without IA from the Copenhagen City Heart Study.

Interventions

None listed

Sponsors

University Hospital, Gentofte, Copenhagen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Persons with a diagnosis of with a confirmed diagnosis of rheumatoid Arthritis or axial spondyloarthritis

Exclusion criteria

* Persons not able to cooperate * Persons unable understand and sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular mortality2-year follow-up
Admission with congestive heart failure2-year follow-up
Myocardial infarction2-year follow-up
Revascularization2-year follow-upPercutaneous coronary intervention or coronary artery bypass graft
Incident Heart Failure2-year follow-up
Incident valvular disease2-year follow-up

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026